Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-13

Clinical Trial Update: Modafinil to Improve Fatiguability [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial is investigating modafinil to reduce fatigability in participants with cancer-related fatigue and cognitive difficulties; the study i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Modafinil (modafinil)

Snippet

Sponsor: Ottawa Hospital Research Institute | Conditions: Cancer-related Cognitive Difficulties, Cancer-related Problem/Condition | Phase 1, Phase 2 | Status: RECRUITING